These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis. Comabella M; Sastre-Garriga J; Carbonell-Mirabent P; Fissolo N; Tur C; Malhotra S; Pareto D; Aymerich FX; Río J; Rovira A; Tintoré M; Montalban X J Neurol Neurosurg Psychiatry; 2022 Apr; ():. PubMed ID: 35487685 [TBL] [Abstract][Full Text] [Related]
14. Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort. Steffen F; Uphaus T; Ripfel N; Fleischer V; Schraad M; Gonzalez-Escamilla G; Engel S; Groppa S; Zipp F; Bittner S Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36411080 [TBL] [Abstract][Full Text] [Related]
15. Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study. Liu C; Lu Y; Wang J; Chang Y; Wang Y; Chen C; Liu Z; Kermode AG; Zhang Y; Qiu W J Neurochem; 2021 Dec; 159(5):913-922. PubMed ID: 34278578 [TBL] [Abstract][Full Text] [Related]